Wikidata entity: Q7553347
C₄H₇NaO₃ (P274)
Quantities
| P2067 | mass | 126.029 |
| P3780 | active ingredient in | ... | Q29006703 (Xyrem) | Xyrem |
| P233 | canonical SMILES | String | C(CC(=O)[O-])CO.[Na+] | ??? |
| P527 | has part(s) | ... | Q658 (sodium) | sodium |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P2175 | medical condition treated | ... | Q189561 (narcolepsy) | narcolepsy |
| P2175 | medical condition treated | ... | Q209733 (chronic fatigue syndrome) | chronic fatigue syndrome |
| P2175 | medical condition treated | ... | Q540571 (fibromyalgia) | fibromyalgia |
| P2175 | medical condition treated | ... | Q751641 (hypersomnia) | hypersomnia |
| P2175 | medical condition treated | ... | Q944473 (cataplexy) | cataplexy |
| P2175 | medical condition treated | ... | Q1869874 (insomnia) | insomnia |
| P2175 | medical condition treated | ... | Q54972453 (sleep-wake disorder) | sleep-wake disorder |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q174723 (codeine) | codeine |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q178566 (chlordiazepoxide) | chlordiazepoxide |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q186257 (lormetazepam) | lormetazepam |
| P769 | significant drug interaction | ... | Q218842 (zolpidem) | zolpidem |
| P769 | significant drug interaction | ... | Q220426 (zopiclone) | zopiclone |
| P769 | significant drug interaction | ... | Q303646 (hydromorphone) | hydromorphone |
| P769 | significant drug interaction | ... | Q319877 (alprazolam) | alprazolam |
| P769 | significant drug interaction | ... | Q377270 (dihydrocodeine) | dihydrocodeine |
| P769 | significant drug interaction | ... | Q407241 (phenobarbital) | phenobarbital |
| P769 | significant drug interaction | ... | Q407535 (oxycodone) | oxycodone |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q407988 (clonazepam) | clonazepam |
| P769 | significant drug interaction | ... | Q210402 (diazepam) | diazepam |
| P769 | significant drug interaction | ... | Q408265 (lorazepam) | lorazepam |
| P769 | significant drug interaction | ... | Q410078 (nitrazepam) | nitrazepam |
| P769 | significant drug interaction | ... | Q412133 (dexmedetomidine) | dexmedetomidine |
| P769 | significant drug interaction | ... | Q412164 (clobazam) | clobazam |
| P769 | significant drug interaction | ... | Q412299 (oxazepam) | oxazepam |
| P769 | significant drug interaction | ... | Q413717 ((RS)-baclofen) | (RS)-baclofen |
| P769 | significant drug interaction | ... | Q414463 (tapentadol) | tapentadol |
| P769 | significant drug interaction | ... | Q417204 (levomepromazine) | levomepromazine |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q418998 (flurazepam) | flurazepam |
| P769 | significant drug interaction | ... | Q420383 (primidone) | primidone |
| P769 | significant drug interaction | ... | Q868658 (perampanel) | perampanel |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q422970 ((±)-promethazine) | (±)-promethazine |
| P769 | significant drug interaction | ... | Q423071 (midazolam) | midazolam |
| P769 | significant drug interaction | ... | Q2622907 (periciazine) | periciazine |
| P769 | significant drug interaction | ... | Q55186498 ((±)-thiopental) | (±)-thiopental |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q50429823 (anesthesia adjuvants) | anesthesia adjuvants |
| P2868 | subject has role | ... | Q50430244 (intravenous anesthetics) | intravenous anesthetics |
| P267 | ATC code | N01AX11 |
| P267 | ATC code | N07XX04 |
| P231 | CAS Registry Number | 502-85-2 |
| P592 | ChEMBL ID | CHEMBL1200682 |
| P661 | ChemSpider ID | 9983 |
| P715 | DrugBank ID | DB09072 |
| P8494 | DSSTOX compound identifier | DTXCID6028866 |
| P3117 | DSSTox substance ID | DTXSID3048940 |
| P232 | EC number | 207-953-3 |
| P2566 | ECHA Substance Infocard ID | 100.007.231 |
| P646 | Freebase ID | /m/02p7d5c |
| P234 | InChI | InChI=1S/C4H8O3.Na/c5-3-1-2-4(6)7;/h5H,1-3H2,(H,6,7);/q;+1/p-1 |
| P235 | InChIKey | XYGBKMMCQDZQOZ-UHFFFAOYSA-M |
| P665 | KEGG ID | D05866 |
| P10245 | MedlinePlus drug identifier | a605032 |
| P486 | MeSH descriptor ID | D012978 |
| P672 | MeSH tree code | D02.241.081.114.937.700 |
| P672 | MeSH tree code | D02.241.511.429.700 |
| P2115 | NDF-RT ID | N0000148768 |
| P2840 | NSC number | 84223 |
| P2840 | NSC number | 755850 |
| P11199 | Probes And Drugs ID | PD002526 |
| P662 | PubChem CID | 23663870 |
| P3345 | RxNorm CUI | 9899 |
| P2877 | SureChEMBL ID | 61823 |
| P2892 | UMLS CUI | C0000503 |
| P2892 | UMLS CUI | C0037537 |
| P11089 | UniChem compound ID | 409747 |
| P652 | UNII | 7G33012534 |
| P11143 | WikiProjectMed ID | Sodium oxybate |
Why not click here or view trends?
log id: 1232411